TY - JOUR
T1 - In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots
AU - Yezhelyev, Maksym V.
AU - Al-Hajj, Ahmad
AU - Morris, Caroline
AU - Marcus, Adam I.
AU - Liu, Tonqrui
AU - Lewis, Melinda
AU - Cohen, Cynthia
AU - Zrazhevskiy, Pasha
AU - Simons, Jonathan W.
AU - Rogatko, Andre
AU - Nie, Shuming
AU - Gao, Xiaohu
AU - O'Regan, Ruth M.
PY - 2007/10/19
Y1 - 2007/10/19
N2 - A study was conducted to demonstrate the use of multicolor quantum dots (QD) for quantitative and in situ profiling multiple biomarkers, using breast cancer cells and clinical tissue specimens. The study also compared and validated the QD-based molecular profiling technology, with standard western blotting (WB) and fluorescence in situ hybridization (FISH). QDs emitting at 525 nm, 565 nm, 605 nm, and 705 nm were directly conjugated, to demonstrate the feasibility of multiplexed labeling. The multicolor QD bioconjugates were used for continuous detection of the five clinically significant tumor markers in breast cancer cells. Two breast cancer cells were selected, as they had different expression levels of the five protein biomarkers. The results of the study show that QD bioconjugates can be used to detect protein biomarkers regardless of their cellular location in breast cancer cells.
AB - A study was conducted to demonstrate the use of multicolor quantum dots (QD) for quantitative and in situ profiling multiple biomarkers, using breast cancer cells and clinical tissue specimens. The study also compared and validated the QD-based molecular profiling technology, with standard western blotting (WB) and fluorescence in situ hybridization (FISH). QDs emitting at 525 nm, 565 nm, 605 nm, and 705 nm were directly conjugated, to demonstrate the feasibility of multiplexed labeling. The multicolor QD bioconjugates were used for continuous detection of the five clinically significant tumor markers in breast cancer cells. Two breast cancer cells were selected, as they had different expression levels of the five protein biomarkers. The results of the study show that QD bioconjugates can be used to detect protein biomarkers regardless of their cellular location in breast cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=35748939704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35748939704&partnerID=8YFLogxK
U2 - 10.1002/adma.200701983
DO - 10.1002/adma.200701983
M3 - Article
AN - SCOPUS:35748939704
SN - 0935-9648
VL - 19
SP - 3146
EP - 3151
JO - Advanced Materials
JF - Advanced Materials
IS - 20
ER -